deCODE Genetics, whose history is very interesting and worth reading [1], was bought by Amgen based on this premise.
Note, however, that SNPs like the one you pointed out are relatively infrequent. Amgen was expecting a two digit % improvement in their pharma pipeline by using GWAS insights.